Eris Lifesciences Q4 results: Net profit to Rs 56.05 crore
Eris Lifesciences Q4 results:
The drug company Eris Lifesciences announced a consolidated net profit increase of 4.02% to Rs 56.05 crore on June 2nd during the quarter ended 31st March 2020.
Eris Lifesciences said in a BSE report that the company reported a net profit of Rs 53.88 crore in January-March of 2018-19.
In the quarter under review the revenue from operations amounted to Rs 248.56 crore, compared to Rs 214.82 crore in last year, it added.
In 2019-20, the company’s net profit stood at Rs 296.29 crore, compared with Rs 291.14 crore a year earlier.
Meanwhile, In the last financial year, operating revenue Rs 1,074.05 crore. In 2018-19 it added that it Rs 982.16 crore.
Besides, on June 2nd, the share price of Eris Lifesciences Ltd trading with the bearish trend. It traded with a loss of 7.60 points reached 520.00 INR with 1.44% down in NSE. Whereas in BSE, it traded with a loss of 8.50 points reached 519.70 INR with 1.61% down.
Stock Market June 2nd Update Sensex and Nifty
Stock Market June 2nd: On the second day of the week, the stock market trading with the bullish trend. The Sensex trading with a gain of 522.01 points reached 33,825.53 level with 1.57% up. Whereas, Nifty trading with a gain of 152.95 points reached 9,979.10 level with 1.56% up.
In the border market, the S&P BSE Midcap trading with a gain of 145.29 points reached 12,302.69 level with 1.20% up. Whereas, S&P BSE SmallCap trading with a gain of 205.65 points reached 11,428.41 with 1.83% up. At the same time, Nifty bank trading with a gain of 570.30 points reached 20,530.20 level with 2.86% up.
Top Gaining Stocks: Zee Entertainment Enterprises, Kotak Mahindra Bank, Bajaj Finserv, Tata Motors, and Bajaj Finance Limited.
Top Losing stocks: Coal India, Maruti Suzuki India, Bharat Petroleum Corp, ITC, and Dr.Reddy’s Laboratories Limited.
